Advisor Group Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$40.6 Billion
Q2 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 53,095 shares of VRTX stock, worth $26.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

53,095

Previous 60,559 12.33%

Holding current value

$26.7 Million

Previous $25.3 Million 1.69%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $2.93 Million - $3.62 Million	-7,464 Reduced 12.33%	53,095 $24.9 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $14.4 Million - $15.8 Million	-35,387 Reduced 36.88%	60,559 $25.3 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $6.94 Million - $8.31 Million	-20,228 Reduced 17.41%	95,946 $39 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $17.3 Million - $18.6 Million	51,198 Added 78.8%	116,174 $40.4 Million
Q2 2023 Aug 21, 2023	SELL	$314.42 - $351.91 $109 Million - $122 Million	-347,049 Reduced 84.23%	64,976 $22.9 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $111 Million - $124 Million	351,873 Added 584.97%	412,025 $145 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $674,087 - $768,978	2,380 Added 4.12%	60,152 $19 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $1.42 Million - $1.59 Million	-4,952 Reduced 7.89%	57,772 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $729,756 - $814,237	2,665 Added 4.44%	62,724 $18.2 Million
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $1.21 Million - $1.51 Million	5,159 Added 9.4%	60,059 $16.9 Million
Q1 2022 May 04, 2022	BUY	$221.42 - $260.97 $4.78 Million - $5.64 Million	21,593 Added 64.83%	54,900 $14.1 Million
Q3 2021 Nov 05, 2021	SELL	$181.39 - $202.99 $740,615 - $828,808	-4,083 Reduced 10.92%	33,307 $6.04 Million
Q2 2021 Aug 02, 2021	SELL	$187.49 - $221.1 $851,017 - $1 Million	-4,539 Reduced 10.83%	37,390 $7.54 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $1.32 Million - $1.54 Million	6,384 Added 17.96%	41,929 $9 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $685,617 - $914,410	3,312 Added 10.28%	35,545 $8.4 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $3.21 Million - $3.8 Million	-12,541 Reduced 28.01%	32,233 $8.81 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $757,387 - $993,592	3,359 Added 8.11%	44,774 $13 Million
Q1 2020 May 18, 2020	BUY	$199.77 - $247.81 $8.27 Million - $10.3 Million	41,415 New	41,415 $7.05 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History